Arca Biopharma, Inc. (ABIO)

Company Overview

ARCA biopharma, Inc. is a biotech company that focuses on the development of genetically-targeted therapies for heart failure. Their main product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator for the treatment of chronic heart failure and other indications. In the development pipeline is rNAPc2, a recombinant protein anticoagulant with a mechanism of action involving inhibition of tissue factor; and NU172, an anticoagulant, used during medical or surgical procedures. ARCA biopharma is working with a collaboration agreement with Laboratory Corporation of America to develop the test for Gencaro.

read more


As of 02:39AM EDT July 29, 2014
$ 1.41   -0.01 (-0.7%)
Today's Open: 1.45 Previous Close: 1.42
Today's High: 1.45 Volume: 81,546
Today's Low: 1.40 Avg Vol: 211,159
52 Week High: 2.54 Bid (size): 5,000
52 Week Low: 1.19 Ask (size): 6,000


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 8001 Arista Place, Suite 200, Broomfield, CO 80021, United States
Mailing Address: -
Phone: 720-940-2200
Fax: 720-208-9261
Website: http//

Company Details:

Symbol: ABIO
SIC: 2835
State location: MN
Sector: -
State of Inc: MN
Employees: 22
Type: -

Key executives:

Name Age Position


Is Arca Biopharma, inc. (NASDAQ:ABIO) Still Cheap? March 28, 2010

Who cares if Arca Biopharma, Inc. (NASDAQ:ABIO) stock tripled on Friday? Arca Biopharmaceutical is a company that over the last 2 years has invested over 60 million dollars in the development of a Heart Failure product. They appear to be making some p... read more


Arca Biopharma, Inc. (ABIO) MESSAGE BOARD

Post # Subject Re Name Date
There are no comments.

Type the characters that you see in the box (5 characters).